On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

Item
http://www.wikidata.org/entity/Q36035643
New developments in atherosclerosis: clinical potential of PCSK9 inhibitionPCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the futureHuman PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials.Emerging innovative therapeutic approaches targeting PCSK9 to lower lipids.PCSK9 in chronic kidney disease.Investigational therapies for hypercholesterolemia.Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy.PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab.Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients.
P2860

On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

Item
http://www.wikidata.org/entity/Q36035643
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
On the function and homeostasi ...... and additional lipid effects.
@ast
On the function and homeostasi ...... and additional lipid effects.
@en
type
label
On the function and homeostasi ...... and additional lipid effects.
@ast
On the function and homeostasi ...... and additional lipid effects.
@en
prefLabel
On the function and homeostasi ...... and additional lipid effects.
@ast
On the function and homeostasi ...... and additional lipid effects.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
On the function and homeostasi ...... and additional lipid effects.
@en
P2093
P2860
P304
P31
P356
10.1016/J.ATHEROSCLEROSIS.2014.12.017
P433
P478
P577
P5875
P698
P932